×
Desvenlafaxine 50 and 100 mg/d Versus Placebo for the Treatment of Major Depressive Disorder: A Phase 4, Randomized Controlled Trial PDF
$ 40.00
Desvenlafaxine 50 and 100 mg/d Versus Placebo for the Treatment of Major Depressive Disorder: A Phase 4, Randomized Controlled Trial PDF quantity
$ 40.00
×
Management of Individuals With Autism Spectrum Disorder in Clinical Settings PDF
$ 40.00
Management of Individuals With Autism Spectrum Disorder in Clinical Settings PDF quantity
$ 40.00
×
Benzodiazepine Prescription Practices and Substance Abuse in Persons With Severe Mental Illness PDF
$ 40.00
Benzodiazepine Prescription Practices and Substance Abuse in Persons With Severe Mental Illness PDF quantity
$ 40.00
×
Should Buprenorphine Induction Dosing Be Lower for the Elderly Population With Opioid Use Disorder? A Case of Buprenorphine-Induced Hemodynamic Instability PDF
$ 40.00
Should Buprenorphine Induction Dosing Be Lower for the Elderly Population With Opioid Use Disorder? A Case of Buprenorphine-Induced Hemodynamic Instability PDF quantity
$ 40.00
×
A Review of l -Methylfolate as Adjunctive Therapy in the Treatment of Major Depressive Disorder PDF
$ 40.00
A Review of l-Methylfolate as Adjunctive Therapy in the Treatment of Major Depressive Disorder PDF quantity
$ 40.00
×
Efficacy of Mirtazapine for Prevention of Depressive Relapse: A Placebo-Controlled Double-Blind Trial of Recently Remitted High-Risk Patients PDF
$ 40.00
Efficacy of Mirtazapine for Prevention of Depressive Relapse: A Placebo-Controlled Double-Blind Trial of Recently Remitted High-Risk Patients PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
